Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Piu Medical SpAMIL:PMED -1.75%14 Return-on-Tangible-Asset is 1.35% as of Jun. 2025, which is 88% below its 10-year median of 11.38. GuruFocus rates MIL:PMED with a GF Score™ of 14/100. The stock has 5 warning signs investors should review. Among 680 Healthcare Providers & Services companies, Piu Medical SpA ranks worse than 64.71% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Piu Medical SpA's annualizedNet Income for the quarter that ended in Jun. 2025 was €0.14 Mil. Piu Medical SpA's average total tangible assets for the quarter that ended in Jun. 2025 was €10.54 Mil. Therefore, Piu Medical SpA's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2025 was 1.35%.
The historical rank and industry rank for Piu Medical SpA's Return-on-Tangible-Asset or its related term are showing as below:
MIL:PMED'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -0.23 Med: 11.38 Max: 13.11
Current: -0.23
During the past 3 years, Piu Medical SpA's highest Return-on-Tangible-Asset was 13.11%. The lowest was -0.23%. And the median was 11.38%.
MIL:PMED's Return-on-Tangible-Asset is ranked worse than 64.71% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 2.505
vs MIL:PMED: -0.23
Piu Medical SpA (MIL:PMED) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Piu Medical SpA Return-on-Tangible-Asset Related Terms
Piu Medical SpA Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Piu Medical SpA's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Piu Medical SpA Return-on-Tangible-Asset Chart
Piu Medical SpA Annual Data
Trend
Dec23
Dec24
Dec25
Return-on-Tangible-Asset
13.11
11.38
-0.19
Piu Medical SpA Semi-Annual Data
Dec23
Dec24
Jun25
Dec25
Return-on-Tangible-Asset
0.00
0.00
1.35
-1.07
Piu Medical SpA Return-on-Tangible-Asset Competitor Comparison
For the Pharmaceutical Retailers subindustry, Piu Medical SpA's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Piu Medical SpA Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Piu Medical SpA's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Piu Medical SpA's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Jun. 2025) net income data.
What does a Return-on-Tangible-Asset of 1.35% mean?
Piu Medical SpA (MIL:PMED) has a Return-on-Tangible-Asset of 1.35% as of Jun. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Piu Medical SpA and its competitors. This is 88% below median its historical median of 11.38. According to the industry distribution chart, Piu Medical SpA ranks #440 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 64.7%.
Is Piu Medical SpA's Return-on-Tangible-Asset too high?
Piu Medical SpA's current Return-on-Tangible-Asset of 1.35% is 88% below median its 10-year median of 11.38. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.51. Piu Medical SpA's value of 1.35% is 46.1% below this industry median. Based on the distribution chart, Piu Medical SpA ranks #440 out of 680 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Piu Medical SpA has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Piu Medical SpA's Return-on-Tangible-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Piu Medical SpA ranks #440 out of 680 companies for Return-on-Tangible-Asset. This places Piu Medical SpA in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.51. Piu Medical SpA's value of 1.35% is 46.1% below this benchmark. While the company's 10-year median is 11.38 vs. the industry median of 2.51, Piu Medical SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.51, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Piu Medical SpA's current Return-on-Tangible-Asset of 1.35% is 46.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Piu Medical SpA and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Piu Medical SpA's current Return-on-Tangible-Asset is 1.35%, which is 88% below median its own 10-year median of 11.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Piu Medical SpA stock overvalued right now?
Piu Medical SpA (MIL:PMED) has a current Return-on-Tangible-Asset of 1.35%. The current Return-on-Tangible-Asset is 1.35%, which is 88% below median its 10-year median of 11.38 and 46.1% below the Healthcare Providers & Services industry median of 2.51. Piu Medical SpA's overall GF Score™ is 14/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Piu Medical SpA (MIL:PMED), the current Return-on-Tangible-Asset is 1.35% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Piu Medical SpA specializes in the retail distribution of pharmaceutical and parapharmaceutical products. Its activity includes: sale of prescription drugs; sale of OTC and parapharmaceutical products: OTC medicines, dietary supplements, medical devices, paramedical products, personal care and wellness products, homeopathic medicines, cosmetics, etc.; services: diagnostic testing services, blood parameter analysis and control (glycemia, cholesterol, triglycerides, etc.), rapid testing and screening, nutritional consultation, remote medical assistance and monitoring, telemedicine, etc.
14GF Score
Get the complete analysis for MIL:PMED
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:PMED has been successfully added to your 
